Contents
Contents
In the AssuredPartners fraud case, the company agreed to a $107 million civil settlement over alleged false Affordable Care Act enrollment involving its then-subsidiary, AP of South Florida. The government alleged that street marketers recruited people at drug treatment clinics, shelters and bus stops, and that false applications obtained insurance subsidies while some consumers lost access to Medicaid or medication assistance. For someone working in enrollment or addiction treatment, that is the disturbing connection in this case. An insurance application could bring money into the business while putting medication out of reach for the person enrolled.
The Justice Department announced the settlement on April 7, 2026. Its civil allegations covered February 2021 through September 2022.
The government alleged that applications inflated consumers’ income and engineered Medicaid denials to obtain Affordable Care Act subsidies. The operation connected street recruitment to insurance enrollment, with insurer commissions financing marketers working around clinics, shelters and bus stops.
A denial of coverage became part of obtaining coverage elsewhere. The government alleged that the operation engineered that result.
The commission-funded recruitment is what connects those decisions to the business incentive. It places the value of an enrollment at the center of the story, before anyone opens a treatment chart. Coverage first. Commissions next.
Drug treatment clinics appear as recruitment locations, and access to opioid and mental health medication appears among the consequences the government attributed to the enrollment scheme. According to the government’s account, false enrollment information caused some consumers to lose access to Medicaid or local medication assistance.
We find that a particularly ugly result for an insurance enrollment business. A consumer could acquire coverage on paper and lose access to medication in practice. An enrollment that earns a commission while interrupting medication access has failed the person it was supposed to help.
The commercial work around addiction treatment helps explain why a health care insider might see the problem outside the billing department. AAC’s 2018 annual filing described addiction websites and a centralized admissions center handling benefits verification, insurer communications, screening, precertification, facility selection and logistics. The filing also described professional and employee-assistance-program relationships. Its admissions model put coverage questions and facility selection in the same operation. Someone could therefore know how a person reached treatment, which insurance was discussed and who arranged the placement without ever preparing a treatment bill.
The worker discussing benefits, the person arranging entry into treatment and the employee handling an insurance application can see different parts of the same consumer’s experience. In the AssuredPartners allegations, the connection to addiction care runs through recruitment, coverage and medication access.
AssuredPartners was the parent company during the alleged civil conduct and the company that agreed to the civil settlement. AP of South Florida was the corporate defendant in a separate criminal case.
The department’s announcement also described AP of South Florida’s agreement to plead guilty. The civil settlement resolved the allegations against the parent, while the brokerage made the criminal agreement.
The Justice Department reported $141.5 million in unwarranted subsidies. We see the imbalance: the parent settled for less than the subsidies the government says the scheme obtained.
For an enrollment insider, the alleged income changes raise a concrete question: did the application describe the consumer or rewrite the consumer’s circumstances?
We would want to understand how the information on an application compared with what the consumer supplied, and who knew about the difference. An application history or communication about income could explain a representation that looks routine in an enrollment report. Medicaid correspondence could explain how a denial became part of obtaining subsidized coverage.
The marketing and payment side answers another question: how an enrollment supported the operation that found the consumer. Lead-source records and commission statements could connect recruitment to revenue. Communications about a consumer losing prior coverage or medication assistance could connect that same enrollment to its effect on care.
Our work with an insider is to connect those views. A person familiar with marketing may know how consumers reached the brokerage. Someone in enrollment may know how their circumstances were represented. A worker in a treatment setting may know what changed when the consumer tried to obtain medication. The case becomes clearer when the application and the experience of the person named on it can be understood together.
A separate criminal indictment involving Sovereign shows why manufactured insurance eligibility belongs in the discussion of addiction-treatment fraud. In that indictment, prosecutors alleged a scheme involving a purported foundation, consumers’ identities, invented qualifying life events, manipulated income and paid premiums to enroll people in subsidized commercial coverage.
In the Sovereign allegations, manipulated enrollment supplied coverage for treatment. In the AssuredPartners case, the government alleged false enrollment information obtained subsidies, while insurer commissions financed the marketing operation. Both accounts put the consumer’s represented eligibility near the beginning of the money trail.
That is why we look beyond treatment claims when an insider describes this kind of conduct. The application can explain how a person became valuable to the operation before a treatment bill existed.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In the AssuredPartners civil case, the Justice Department stated a $24.3 million whistleblower share of the recovery.
The award makes the value of an insider’s account concrete. For someone who understands the enrollment operation, the conversation starts with what the business represented about its consumers and what that information helped it obtain.
If you saw income changed, Medicaid denials engineered or consumers lose medication access after enrollment, talk with our whistleblower experts about what happened inside the operation. We work with you to build the case around that knowledge and bring in healthcare fraud whistleblower lawyers who understand insurance enrollment and federal subsidies. We stay beside you through the process, working to build your strongest enrollment fraud whistleblower case.